U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.337T>G (p.Phe113Val) AND Li-Fraumeni syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 5, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000633376.13

Allele description [Variation Report for NM_000546.6(TP53):c.337T>G (p.Phe113Val)]

NM_000546.6(TP53):c.337T>G (p.Phe113Val)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.337T>G (p.Phe113Val)
HGVS:
  • NC_000017.11:g.7676032A>C
  • NG_017013.2:g.16519T>G
  • NM_000546.6:c.337T>GMANE SELECT
  • NM_001126112.3:c.337T>G
  • NM_001126113.3:c.337T>G
  • NM_001126114.3:c.337T>G
  • NM_001126118.2:c.220T>G
  • NM_001276695.3:c.220T>G
  • NM_001276696.3:c.220T>G
  • NM_001276760.3:c.220T>G
  • NM_001276761.3:c.220T>G
  • NP_000537.3:p.Phe113Val
  • NP_000537.3:p.Phe113Val
  • NP_001119584.1:p.Phe113Val
  • NP_001119585.1:p.Phe113Val
  • NP_001119586.1:p.Phe113Val
  • NP_001119590.1:p.Phe74Val
  • NP_001263624.1:p.Phe74Val
  • NP_001263625.1:p.Phe74Val
  • NP_001263689.1:p.Phe74Val
  • NP_001263690.1:p.Phe74Val
  • LRG_321t1:c.337T>G
  • LRG_321:g.16519T>G
  • LRG_321p1:p.Phe113Val
  • NC_000017.10:g.7579350A>C
  • NM_000546.4:c.337T>G
  • NM_000546.5:c.337T>G
  • P04637:p.Phe113Val
  • p.F113V
Protein change:
F113V
Links:
UniProtKB: P04637#VAR_033033; dbSNP: rs587781642
Molecular consequence:
  • NM_000546.6:c.337T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.337T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.337T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.337T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.220T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.220T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.220T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.220T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.220T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000754598Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 5, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

PubMed [citation]
PMID:
12826609
PMCID:
PMC166245

Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.

Norris SA, Kessler HA, Fife KH.

J Infect Dis. 1988 Jan;157(1):209-10. No abstract available.

PubMed [citation]
PMID:
2826609
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000754598.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 113 of the TP53 protein (p.Phe113Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TP53-related conditions. ClinVar contains an entry for this variant (Variation ID: 141302). Invitae Evidence Modeling incorporating data from in vitro experimental studies (PMID: 12826609, 29979965, 30224644) indicates that this missense variant is expected to disrupt TP53 function with a positive predictive value of 97.5%. Experimental studies have shown that this missense change affects TP53 function (PMID: 2826609, 29979965, 30224644). This variant disrupts the p.Phe113 amino acid residue in TP53. Other variant(s) that disrupt this residue have been observed in individuals with TP53-related conditions (PMID: 17554785; internal data), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 14, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search